Axinn Partner Chad Landmon was quoted in the Bloomberg BNA Pharmaceutical Law & Industry Report article, "Ranbaxy Loses Bid to Block Other Firms' Nexium, Valcyte Generic Products."

Click here to access the Bloomberg BNA Pharmaceutical Law & Industry Report. A subscription is required.